LIB Therapeutics Announces Appointment of Ingrid Choong, PhD as Chief Business Officer as Company Pr
Industry veteran brings more than 20 years of broad operational experience in emerging-stage, private and publicly traded biotechnology companies with an established track record in global clinical development, regulatory strategy, business development, partnering, and corporate communicationsLerodalcibep, a novel,...